Salicylates Group

These substances were identified for action under the Chemicals Management Plan (CMP). This screening assessment focuses on 5 substances referred to collectively as the Salicylates Group.

Information sheet

Salicylates Group

Summary of publications
Timelines

Summary of publications

**Summary of publications**
Substance group	CAS RN	Common name	DSL name	Draft screening assessment	Risk management scope	Proposed conclusion on section 64 criteria	Follow-up activities
Salicylates Group	69-72-7	Salicylic acid	Benzoic acid, 2-hydroxy-	HTML	HTML	Meets one or more of the criteria	Refer to risk management scope
	87-22-9	Phenethyl salicylate	Benzoic acid, 2-hydroxy-, 2-phenylethyl ester		None	Does not meet	Under consideration
	118-56-9	Homosalate	Benzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester		HTML	Meets one or more of the criteria	Refer to risk management scope
	68917-75-9^{Footnote a}	Wintergreen oil	Oils, wintergreen		HTML	Meets one or more of the criteria	Refer to risk management scope
	84012-15-7^{Footnote a}	Betula alba extract	Birch, Betula alba, ext.		None	Does not meet	None planned at this time
Footnote a This CAS RN is a UVCB (unknown or variable composition, complex reaction products, or biological materials). Return to footnote a referrer

Timelines

**Timelines**
Date	Activity
March 2021	Anticipated publication of the Final Screening Assessment for the Salicylates Group and the Proposed Risk Management Approach for Wintergreen Oil, Salicylic Acid and Homosalate
March 14, 2020	Publication and start of 60-day public comment period on the Draft Screening Assessment for the Salicylates Group and the Risk Management Scope for Wintergreen Oil, Salicylic Acid and Homosalate. The related notice was published in the Canada Gazette, Part I: Vol. 154, No. 11 .

Page details

Date modified:: 2020-03-13